Acesso livre
Acesso livre

Reumatologia Pediátrica

Diretrizes ACR para o tratamento da artrite idiopática juvenil.

8 Mar, 2022 | 16:01h

Comunicado de imprensa: The American College of Rheumatology releases two updated guidelines for treatment of juvenile idiopathic arthritis – American College of Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging – Arthritis & Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Novidades na ortopedia pediátrica.

25 Fev, 2022 | 14:05h

What’s New in Pediatric Orthopaedics – The Journal of Bone & Joint Surgery

Tratamento anti-inflamatório da doença de Kawasaki: comparação das atuais diretrizes e perspectivas.

25 Fev, 2022 | 13:59h

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives – Frontiers in Medicine

Revisão | Artrite idiopática juvenil.

28 Jan, 2022 | 16:50h

Juvenile idiopathic arthritis – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Infográfico: Juvenile idiopathic arthritis (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 

Revisão | Tratamento da síndrome inflamatória multissistêmica (MIS-C) em crianças e adolescentes.

20 Jan, 2022 | 21:27h

Treatment of MIS-C in Children and Adolescents – Current Pediatrics Reports

Ver também: Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations – World Journal of Pediatrics

Conteúdos relacionados:

Review of 4,470 cases of Multisystem Inflammatory Syndrome in Children in the US.

WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19.

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Revisão sistemática | Órteses de pé para tratamento de pé chato pediátrico.

20 Jan, 2022 | 20:40h

Foot orthoses for treating paediatric flat feet – Cochrane Library

Resumo: Foot orthoses for treating flat feet in children – Cochrane Library

Em um estudo com 1.110 crianças com febre prolongada, os níveis sorológicos de MRP8/14 foram validados como marcador diagnóstico para artrite idiopática juvenil sistêmica.

17 Jan, 2022 | 12:53h

MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever – Rheumatology (link para o resumo – $ para o texto completo)

Comentário: It is about time: the first validated biomarker for early diagnosis of sJIA – Rheumatology

 

Exames de imagem na osteomielite não bacteriana em crianças e adolescentes: diagnóstico, diagnóstico diferencial e seguimento – Uma revisão educacional baseada em pesquisa da literatura e em experiência clínica própria.

8 Out, 2021 | 10:52h

Imaging in non-bacterial osteomyelitis in children and adolescents: diagnosis, differential diagnosis and follow-up—an educational review based on a literature survey and own clinical experiences – Insights into Imaging

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.